Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Valeant Pharma (VRX) Applies for MCTO with Canadian Securities Regulator AMF
May 17, 2016 6:42 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) provided an update on regulatory matters.
The Company announced that, on May 11, 2016, it applied for a customary management cease trade order ("MCTO") from the Autorité des marchés financiers (the "AMF"), the Company's principal securities regulator in Canada, relating... More
Valeant Pharma (VRX) will hold annual meeting on June 14th - Bloomberg
May 16, 2016 10:29 AM EDTValeant Pharma (NYSE: VRX) will hold annual meeting on June 14th, according to Bloomberg headlines.
... More